[Skip to Content]

avastin; bevacizumab

The Royal College of Ophthalmologists is delighted at landmark ruling in favour of the use of Avastin for wet AMD

The Royal College of Ophthalmologists (RCOphth) welcomes the High Court decision that has found in favour for the use of bevacizumab (Avastin) in the treatment of wet age related macular degeneration (wet AMD).  Wet AMD is the biggest cause of vision loss in the UK and the hospital eye service is dealing with over 40,000